Browse 24807 Federal Health Grants below, sorted by the deadline to apply.
The United States Government agency or department offering the grant is also listed.
Select a specific Health grant to read the full description of the opportunity.
The full description contains the grant type, total award amount, eligible applicants, important dates, and official contact details.
If you wish to search for a specific keyword or view grants sorted by governmental agency, use the links on the menu bar.
Close Date | Grant Title | Agency |
July 30th, 2020 |
Genomic Predictors of Pregnancy Loss (R01 Clinical Trial Not Allowed) |
National Institutes of Health |
February 4th, 2022 |
Novel Synthetic Nucleic Acid Technology Development (R43/R44)( Clinical Trial not allowed) |
National Institutes of Health |
February 4th, 2022 |
Novel Synthetic Nucleic Acid Technology Development (R01 Clinical Trial not allowed) |
National Institutes of Health |
May 15th, 2020 |
Firearm Injury and Mortality Prevention Research (R61 Clinical Trial Optional) |
National Institutes of Health |
January 7th, 2023 |
Formative and Pilot Intervention Research for Prevention and Treatment of HIV/AIDS (R34 Clinical Trial Optional) |
National Institutes of Health |
February 4th, 2022 |
Novel Synthetic Nucleic Acid Technology Development (R21 Clinical Trial not allowed) |
National Institutes of Health |
May 18th, 2020 |
BJA FY 20 The Justice and Mental Health Collaboration Program |
Bureau of Justice Assistance |
May 20th, 2020 |
American Schools and Hospitals Abroad Program Worldwide |
Agency for International Development |
March 19th, 2020 |
FY 2018 American Schools and Hospitals Abroad (ASHA) Program |
Agency for International Development |
May 22nd, 2020 |
Patient-oriented Research to Mitigate Health Disparities and Lessen the Burden of Chronic Diseases Within the Mission of NIDDK (R01 Clinical Trial Optional) |
National Institutes of Health |
July 8th, 2020 |
Firearm Injury Surveillance Through Emergency Rooms (FASTER) |
Centers for Disease Control NCIPC |
April 16th, 2020 |
Supporting business and professional associations in Azerbaijan |
Azerbaijan USAID Baku |
December 8th, 2020 |
Exploratory/Developmental Grants Related to the World Trade Center Health Program (R21) |
Centers for Disease Control and Prevention ERA |
December 11th, 2020 |
Extension of the World Trade Center Health Registry |
Centers for Disease Control and Prevention ERA |
May 7th, 2023 |
Catalytic Tool and Technology Development in Kidney, Urologic, and Hematologic Diseases (R21 Clinical Trial Not Allowed) |
National Institutes of Health |
July 30th, 2021 |
Research to Reduce Morbidity and Improve Care for Pediatric, and Adolescent and Young Adult (AYA) Cancer Survivors (R21 Clinical Trial Optional) |
National Institutes of Health |
July 30th, 2021 |
Research to Reduce Morbidity and Improve Care for Pediatric, and Adolescent and Young Adult (AYA) Cancer Survivors (R01 Clinical Trial Optional) |
National Institutes of Health |
May 7th, 2023 |
Center of Excellence for Research on Complementary and Integrative Health (P01,Clinical Trial Optional) |
National Institutes of Health |
July 31st, 2020 |
Defining Lineage Plasticity and Endogenous Regeneration Capacity of Dental, Oral, and Craniofacial Tissues (R21 Clinical Trial Not Allowed) |
National Institutes of Health |
June 30th, 2020 |
Postdoctoral Training in Pediatric Clinical Pharmacology (T32 Clinical Trial Not Allowed) |
National Institutes of Health |
|
July 30th, 2020 |
Population Dynamics Centers Research Infrastructure Program FY 2021 (P2C Clinical Trial Not Allowed) |
National Institutes of Health |
January 13th, 2023 |
Investigator Initiated Extended Clinical Trial (R01 Clinical Trial Required) |
National Institutes of Health |
July 31st, 2020 |
Defining Lineage Plasticity and Endogenous Regeneration Capacity of Dental, Oral, and Craniofacial Tissues (R01 Clinical Trial Not Allowed) |
National Institutes of Health |
June 8th, 2020 |
Limited Competition: Sickle Pan-African Research Consortium Clinical Coordinating Center (U24 Clinical Trial Optional) |
National Institutes of Health |
November 5th, 2022 |
In-Depth Phenotyping and Research Using IMPC-Generated Knockout Mouse Strains Exhibiting Embryonic or Perinatal Lethality or Subviability (R01 Clinical Trial Not Allowed) |
National Institutes of Health |
October 1st, 2020 |
Artificial Intelligence and Technology Collaboratories for Aging Research Coordinating Center (AITCC) (R24 Clinical Trial Not Allowed) |
National Institutes of Health |
July 8th, 2020 |
NHGRI Technology Development Coordinating Center (U24 Clinical Trial Not Allowed) |
National Institutes of Health |
May 15th, 2020 |
National Public Health Surveillance for Chemical and Radiologic Exposures and Emerging Drug Threats |
Centers for Disease Control NCEH |
May 7th, 2023 |
Research Projects to Enhance Applicability of Mammalian Models for Translational Research (R01 Clinical Trial Not Allowed) |
National Institutes of Health |
June 8th, 2020 |
Sickle Pan-African Research Consortium Collaborative Sites (U01 Clinical Trial Optional) |
National Institutes of Health |
June 8th, 2020 |
Limited Competition: Sickle Africa Data Coordinating Center (U24 Clinical Trial Optional) |
National Institutes of Health |
October 1st, 2020 |
Artificial Intelligence and Technology Collaboratories for Aging Research (P30 Clinical Trial Optional) |
National Institutes of Health |
May 14th, 2020 |
Strengthening Public Health Systems and Services through National Partnerships to Improve and Protect the Nation's Health |
Centers for Disease Control OSTLTS |
August 11th, 2020 |
Pregnancy Risk Assessment Monitoring System (PRAMS) |
Centers for Disease Control and Prevention ERA |
July 29th, 2020 |
Core Infrastructure Support for Cancer Epidemiology Cohorts (U01 Clinical Trial Not Allowed) |
National Institutes of Health |
July 22nd, 2020 |
Kidney Technology Development Research Education Program (R25 - Independent Clinical Trial Not Allowed) |
National Institutes of Health |
June 8th, 2021 |
Development of Wearable Smart Devices for Continuous Monitoring of Circulating Nutrients, Metabolites and Hormones (R21/R33 Clinical Trial Required) |
National Institutes of Health |
June 29th, 2020 |
Partnerships for Countermeasures against Select Pathogens (R01 Clinical Trials Not Allowed) |
National Institutes of Health |
June 8th, 2021 |
Gastrointestinal (GI) and Microbiome Explorers: Development of Swallowable Smart Pills or Devices for Precision Nutrition, Microbiome and Digestive Disease Applications (R21/R33 Clinical Trial Required) |
National Institutes of Health |
March 11th, 2023 |
Broad Mission Announcement for USAID/Ethiopia |
Ethiopia USAID Addis Ababa |